BARN 📈 Barry Callebaut - Overview
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0009002962
BARN: Chocolate, Cocoa, Fillings, Coatings, Nuts, Decorations
Barry Callebaut AG is a leading global manufacturer of chocolate and cocoa products, operating through a diverse range of subsidiaries. The company's product portfolio is extensive, encompassing a wide variety of chocolates, compounds, and cocoa-based products, including cocoa powder, chocolate drinks, and cappuccinos. Additionally, it offers a range of dairy and non-dairy products, tea, coffee, and other specialty items like fillings, coatings, nuts, and decorations. This broad product range enables the company to cater to a wide range of customers, from food manufacturers and artisans to professional users of chocolate, such as chocolatiers, pastry chefs, and bakers.
The company's products are marketed under numerous brand names, including American Almond, Barry Callebaut, Cacao Barry, and Van Houten, among others. This multi-brand strategy allows the company to target different market segments and customer groups, enhancing its overall market presence and competitiveness. Furthermore, Barry Callebaut AG provides a range of support services, including centralized treasury and management services, captive reinsurance, and research and development services. The company's CHOCOLATE ACADEMY centers also offer conference and training services, which help to foster innovation and expertise in the use of chocolate and cocoa products.
Barry Callebaut AG's customer base is diverse, spanning food manufacturers, artisans, and professional users of chocolate. The company's products are used in a variety of applications, from vending machines to high-end pastry shops and restaurants. Geographically, the company operates primarily in Western Europe, North America, Central and Eastern Europe, Latin America, and other international markets. With its headquarters in Zurich, Switzerland, Barry Callebaut AG is well-positioned to serve its global customer base and capitalize on emerging trends and opportunities in the chocolate and cocoa industry. The company's common stock is listed under the ISIN CH0009002962 and is classified under the GICS Sub Industry of Packaged Foods & Meats.
Additional Sources for BARN Stock
BARN Stock Overview
Market Cap in USD | 8,627m |
Sector | Consumer Defensive |
Industry | Confectioners |
GiC Sub-Industry | Packaged Foods & Meats |
IPO / Inception |
BARN Stock Ratings
Growth 5y | -52.8% |
Fundamental | 22.8% |
Dividend | 59.7% |
Rel. Strength Industry | -187 |
Analysts | - |
Fair Price Momentum | 1114.69 CHF |
Fair Price DCF | - |
BARN Dividends
Dividend Yield 12m | 4.78% |
Yield on Cost 5y | 2.91% |
Annual Growth 5y | 3.13% |
Payout Consistency | 86.6% |
BARN Growth Ratios
Growth Correlation 3m | -87.7% |
Growth Correlation 12m | 35.3% |
Growth Correlation 5y | -62.6% |
CAGR 5y | -9.53% |
CAGR/Mean DD 5y | -0.51 |
Sharpe Ratio 12m | -0.44 |
Alpha | -21.53 |
Beta | 0.22 |
Volatility | 18.84% |
Current Volume | 21.8k |
Average Volume 20d | 11.7k |
As of December 21, 2024, the stock is trading at CHF 1205.00 with a total of 21,772 shares traded.
Over the past week, the price has changed by -5.16%, over one month by -7.75%, over three months by -20.13% and over the past year by -11.83%.
Neither. Based on ValueRay Fundamental Analyses, Barry Callebaut is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 22.81 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BARN as of December 2024 is 1114.69. This means that BARN is currently overvalued and has a potential downside of -7.49%.
Barry Callebaut has no consensus analysts rating.
According to ValueRays Forecast Model, BARN Barry Callebaut will be worth about 1204.3 in December 2025. The stock is currently trading at 1205.00. This means that the stock has a potential downside of -0.06%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 1768.4 | 46.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 1204.3 | -0.1% |